ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,114Medicare Part D Prescriptions Filled, Including Refills

Rank: 60 out of 288

$522K Total Retail Price of All Prescriptions

Rank: 66 out of 288

609 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 609 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 609 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 10,091 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 530 490 1 1
OMEPRAZOLE 448 420 2 3
LEVOTHYROXINE SODIUM 403 391 3 2
HYDROCODONE-ACETAMINOPHEN 358 304 S3 4 7
WARFARIN SODIUM 253 247 5 9
ATORVASTATIN CALCIUM 237 229 6 14
ZOLPIDEM TARTRATE 222 185 7 22
AMLODIPINE BESYLATE 212 203 8 6
ALENDRONATE SODIUM 199 199 9 20
FUROSEMIDE 195 165 10 5
METOPROLOL TARTRATE 193 185 11 8
CITALOPRAM HBR 191 161 12 18
LISINOPRIL 191 176 12 4
ATENOLOL 174 157 14 10
GABAPENTIN 161 159 15 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 147 142 16 34
FLUTICASONE PROPIONATE 143 142 17 41
PRAVASTATIN SODIUM 139 121 18 21
PANTOPRAZOLE SODIUM 139 110 18 42
POTASSIUM CHLORIDE 138 122 20 11
SERTRALINE HCL 135 121 21 25
PREDNISONE 134 121 22 30
TAMSULOSIN HCL 123 100 23 24
TRAMADOL HCL 109 104 24 19
CRESTOR 109 91 24 26
HYDROCHLOROTHIAZIDE 104 101 26 13
MELOXICAM 103 77 27 44
METFORMIN HCL 99 93 28 12
OXYBUTYNIN CHLORIDE ER 86 85 29 116
METOPROLOL SUCCINATE 85 85 30 15
FENTANYL 81 68 S2 31 57
MIRTAZAPINE 78 78 32 60
ALLOPURINOL 78 75 32 23
TRIAMTERENE-HCTZ 76 76 34 28
PROAIR HFA 73 67 35 45
CARVEDILOL 65 57 36 27
LOSARTAN POTASSIUM 64 61 37 16
PAROXETINE HCL 64 62 37 54
DIOVAN 61 61 39 53
TRAZODONE HCL 60 49 40 37
METFORMIN HCL ER 60 56 40 76
FLUOXETINE HCL 57 57 42 64
LANTUS SOLOSTAR 57 51 42 81
VERAPAMIL ER 57 57 42 97
ROPINIROLE HCL 54 41 45 74
BENAZEPRIL HCL 54 54 45 52
KLOR-CON M20 54 49 45 110
ADVAIR DISKUS 53 45 48 50
PREMARIN 52 51 R 49 143
LIDODERM 51 48 50 157
CLOPIDOGREL 50 50 51 47
ESCITALOPRAM OXALATE 50 41 51 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.